phone-icon(+035) 527-1710-70
email-icongoogle@gmail.com
map-iconChoose an address
Eastgate Biotech Eastgate Biotech
  • Home
  • About Us
    • Management
  • Technology
    • Research
    • Intraoral Insulin
  • Products
  • Investors
    • Press Releases
    • SEC Filings
  • Media
    • Dr. Luc Duchesne
    • Investor Intel
    • Investor Wired
    • StockHouse
    • TechSonian
    • PharmaLot
  • Contact Us
Menu
Eastgate Biotech Eastgate Biotech
  • NEWSLETTER
  • CONTACT US
  • FAQs
  • SPECIAL OFFER
  • PURCHASE THEME

Uncategorized

Home » Archive by Category "Uncategorized"
12 Nov
Partnership News, Uncategorized

Eastgate Biotech Corp.’s JV partner acquired Raymond Pharmaceutical facility

  • November 12, 2024
  • By author-avatar Eastgate
  • 0 comments
Eastgate Biotech Corp.'s JV partner acquired Raymond Pharmaceutical facility. The 22,000 square meter facility produces some 40 millio...

Continue reading

09 Mar
Uncategorized

Link to interview with Ms. Anna Gluskin, CEO, Eastgate Biotech Corp. on Wall Street Analyzer

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
https://wallstreetanalyzer.com/2019/05/02/eastgate-biotech-corp-otcbb-etbi-interview-with-ceo-anna-gluskin/

Continue reading

09 Mar
Uncategorized

Gunpowder Capital Corp. Provides Update on EastGate

  • March 9, 2022
  • By author-avatar admin
  • 0 comments

Continue reading

17 May
Uncategorized

EastGate Biotech Corp. enters into a 3-way International Distribution Agreement with Dr. Upadhyay Vedic Research Laboratories and ImmunoJuvenate, Inc.

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
The terms of the distribution agreement allow ImmunoJuvenate to market an entire product catalog under Private label in the United ...

Continue reading

09 Mar
Uncategorized

EastGate Biotech Pakistan Expands its Collaboration in Advancing the Development of a New Vaccine Against COVID-19

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
Joint Venture Collaboration to also pursue antibiotic products to create a pipeline to fight various new strains of flu illnesses...

Continue reading

09 Mar
Uncategorized

EastGate Biotech Discusses Their Phase 3 Clinical Trials and Recent Coronavirus Agreement

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
EastGate Biotech Discusses Their Phase 3 Clinical Trials and Recent Coronavirus Agreement   Phoenix, Arizona--(Newsfile ...

Continue reading

09 Mar
Uncategorized

EastGate Biotech Pakistan Receives International Marketing Rights of Anaferon an Approved Coronavirus Treatment to Potentially Combat the Wuhan Coronavirus

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
WEST CALDWELL, NJ and TORONTO, ON /NEWMEDIAWIRE/ January 29, 2020,/ EastGate Biotech Corp. (OTC: PINK: ETBI), a pharmaceutical company,...

Continue reading

09 Mar
Uncategorized

EastGate Biotech Provides Summary of 2019 Corporate and Development Highlights

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
EastGate Biotech Provides Summary of 2019 Corporate and Development Highlights     WEST CALDWELL, NJ and TORONTO, O...

Continue reading

09 Mar
Uncategorized

EastGate Biotech Expands Pipeline to Alzheimer’s Disease Using its Alternative Insulin Delivery Platform

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
EastGate Biotech Corp. announced today that it has initiated plans to expand its alternative insulin delivery portfolio to apply to the...

Continue reading

09 Mar
Uncategorized

EastGate Biotech Announces Expansion and Restructuring of Joint Venture with its Partner in Pakistan

  • March 9, 2022
  • By author-avatar admin
  • 0 comments
Key products to be tested, registered and marketed include Insugin for diabetes application, alternative insulin for Alzheimer’s applic...

Continue reading

  • 1
  • 2
  • 3
  • ›
  • »

EastGate Biotech produces and distributes innovative and healthy nutraceuticals that are based on natural therapies and absorbed naturally by the body.

2203-65 Harbour Square Toronto, Ontario M5J 2L4 Canada
Phone: +1 647 692 0652
WhatsApp: +1 647 692 0652
Our Office
  • New York
  • London SF
  • Cockfosters BP
  • Los Angeles
  • Chicago
  • Las Vegas
Innovative Alternatives to Conventional Pharmaceuticals.
  • Home
  • About Us
    • Management
  • Technology
    • Research
    • Intraoral Insulin
  • Products
  • Investors
    • Press Releases
    • SEC Filings
  • Media
    • Dr. Luc Duchesne
    • Investor Intel
    • Investor Wired
    • StockHouse
    • TechSonian
    • PharmaLot
  • Contact Us
  • Compare